Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magali Traskine

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Pediatric Infectious Disease Journal|May 23, 2019
Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as ToddlersTerry Nolan, Robert Booy, Helen S Marshall, et al.
Journal of the Pediatric Infectious Diseases Society|April 30, 2016
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in FinlandTimo Vesikari, Aino Forsten, Ilkka Seppä, et al.
The Lancet. Infectious Diseases|November 30, 2013
Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trialArto A Palmu, Jukka Jokinen, Heta Nieminen, et al.
Vaccine|October 21, 2019
Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized studyLaura L Hammitt, James C Campbell, Dorota Borys, et al.
Expert Review of Vaccines|December 10, 2020
Can two different pneumococcal conjugate vaccines be used to complete the infant vaccination series? A randomized trial exploring interchangeability of the 13-valent pneumococcal conjugate vaccine and the pneumococcal non-typeable <i>Haemophilus influenzae</i> protein D-conjugate vaccineAbiel Mascareñas de Los Santos, Miguel Angel Rodríguez-Weber, Pedro Sánchez-Márquez, et al.
Vaccine|July 29, 2018
Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre studyAlfonso Carmona Martinez, Roman Prymula, Mariano Miranda Valdivieso, et al.
Vaccine|April 13, 2019
Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infantsAderonke Odutola, Martin O C Ota, Martin Antonio, et al.
The Journal of Infectious Diseases|July 21, 2020
A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive AdultsJames E Moon, Christian Ockenhouse, Jason A Regules, et al.
Human Vaccines & Immunotherapeutics|January 18, 2020
Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01<sub>E</sub> malaria vaccine in African children: a randomized trialInnocent Valéa, Samuel Adjei, Effua Usuf, et al.
Vaccine|April 9, 2017
Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind studyAderonke Odutola, Martin O C Ota, Martin Antonio, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Pediatric Infectious Disease Journal|May 23, 2019
Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as ToddlersTerry Nolan, Robert Booy, Helen S Marshall, et al.
Journal of the Pediatric Infectious Diseases Society|April 30, 2016
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in FinlandTimo Vesikari, Aino Forsten, Ilkka Seppä, et al.
The Lancet. Infectious Diseases|November 30, 2013
Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trialArto A Palmu, Jukka Jokinen, Heta Nieminen, et al.
Vaccine|October 21, 2019
Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized studyLaura L Hammitt, James C Campbell, Dorota Borys, et al.
Expert Review of Vaccines|December 10, 2020
Can two different pneumococcal conjugate vaccines be used to complete the infant vaccination series? A randomized trial exploring interchangeability of the 13-valent pneumococcal conjugate vaccine and the pneumococcal non-typeable <i>Haemophilus influenzae</i> protein D-conjugate vaccineAbiel Mascareñas de Los Santos, Miguel Angel Rodríguez-Weber, Pedro Sánchez-Márquez, et al.
Vaccine|July 29, 2018
Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre studyAlfonso Carmona Martinez, Roman Prymula, Mariano Miranda Valdivieso, et al.
Vaccine|April 13, 2019
Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infantsAderonke Odutola, Martin O C Ota, Martin Antonio, et al.
The Journal of Infectious Diseases|July 21, 2020
A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive AdultsJames E Moon, Christian Ockenhouse, Jason A Regules, et al.
Human Vaccines & Immunotherapeutics|January 18, 2020
Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01<sub>E</sub> malaria vaccine in African children: a randomized trialInnocent Valéa, Samuel Adjei, Effua Usuf, et al.
Vaccine|April 9, 2017
Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind studyAderonke Odutola, Martin O C Ota, Martin Antonio, et al.
Pageof 2